In vivo studies suggest a relationship between SPN and p53, similarly to pRB and p53, since the loss of both genes increased the incidence of tumors (e.g., lymphomas) and neoplastic lesions in the mammary glands 3. This evidence concerns the gene TP53 and lymphoma.